TPG-backed Bicara Therapeutics raises $315 mln in US IPO
Sept 12 (Reuters) - Bicara Therapeutics BCAX.O raised $315 million in its initial public offering in the United States, the TPG-backed cancer therapy developer said on Thursday. (Reporting by Gnaneshwar Rajan and Arasu Kannagi Basil in Bengaluru; Editing by Alan Barona) ((Gnaneshwar.Rajan@thomsonreuters.com))
Recent news on Bicara Therapeutics
See all newsBrief: Bicara Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
U.S. RESEARCH ROUNDUP-Cardinal Health, Lumentum Holdings, Public Storage
Bicara Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Bicara Therapeutics Appoints Ryan Cohlhepp As President & CEO Effective January 2027
Brief: Bicara Therapeutics Announces Appointments Of Jeremy Bender And Christy Oliger To Board Of Directors